Seoul St. Mary's Hospital
Clinical trials sponsored by Seoul St. Mary's Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Your genes might predict a hidden heart risk Results expected Dec 2026 (estimated)
- Glow-in-the-Dark dye helps surgeons find colon cancer Results expected Dec 2026 (estimated)
- Catheter timing could cut infections and speed recovery after colorectal surgery Results expected Dec 2026 (estimated)
- Could a diabetes drug help hearts stiffened by amyloid? Results expected Apr 2027 (estimated)
-
Could a diabetes drug help hearts stiffened by amyloid?
Disease control Recruiting nowThis study tests whether Enavogliflozin, a drug used for diabetes, can help people with amyloid cardiomyopathy, a condition where abnormal proteins build up in the heart. About 68 adults with heart failure symptoms will take the drug or a placebo for 12 weeks, then switch. The ma…
Phase 4 • Sponsor: Seoul St. Mary's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Your genes might predict a hidden heart risk
Knowledge-focused Recruiting nowThis study looks at whether a person's genetic makeup can help spot undiagnosed atrial fibrillation (AF), an irregular heartbeat that raises stroke risk. About 800 adults with symptoms or risk factors will wear a heart monitor for 7 days and use a handheld ECG device at home for …
Sponsor: Seoul St. Mary's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC